Scientists Map Genetic Evolution Of Leukaemia Through MDS Patients
2 Dec. 2012Here is a new article by the Washington University in St. Louis, School of Medicine:
This article deals with the need to develop cancer drugs that target specific gene mutations that develop in MDS.
Introduction: “By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, MD, and Matthew Walter, MD, from the Washington University in St. Louis, School of Medicine, have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop early in the disease.”
Read the full article, published 14/03/2012, here.
